CDEK
← All organizations

Rare Disease Therapeutics

For profitContributed to NME

Also known as: Rare Disease Research, LLC | Rare Disease Therapeutics Inc. | Rare Disease Therapeutics, Inc. (RDT)

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Aug 1, 2009

First marketed drug

Jul 27, 2011

First NDA

Aug 3, 2011

Last known activity

Jul 1, 2021

Timeline

1990s

  1. Jan 1, 1991

    Rare Disease Therapeutics— Founded

2010s

  1. Jul 27, 2011

    Coccidioides immitis Spherule - Derived Skin Test Antigen— Marketing Organization

  2. Aug 3, 2011

    centruroides (scorpion) immune f(ab')2 (equine) injection— NDA Organization

  3. May 6, 2015

    crotalidae immune f(ab')2 (equine)— NDA Secondary Org

Drugs by trial phase (3 distinct, 3 trials)

Phase 4 (1 own, 0 via acquisition)

Marketed drugs (3)

Recent trials (3)

Details

Founded
Nashville, TN, US Jan 1, 1991
First NDA
Aug 3, 2011
Last known activity
Jul 1, 2021

Designations held

  • Orphan drug